Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use COBENFY safely and effectively. See full prescribing information for COBENFY. COBENFY™ (xanomeline and trospium chloride) capsules, for oral use Initial U.S. Approval: 2024
Medication labelWhy this: Advisory · dailymed-prescription
COBENFY is indicated for the treatment of schizophrenia in adults.
- generic_name
- xanomeline and trospium chloride
- product_names
- xanomeline and trospium chloride
- ndc
- 0003-0050, 0003-0050-60, 0003-0050-14, 0003-0050-98, 0003-1100, 0003-1100-60, 0003-1100-14, 0003-1100-98, 0003-0125, 0003-0125-60, 0003-0125-14, 0003-0125-98, 0003-5200, 0003-5200-56, 0003-0050-04, 0003-1100-01, 0003-5150, 0003-5150-14, 0003-0050-00, 0003-1100-10
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en